Detailed Description:
An open two stage non-randomized Phase 1 study with the participation of healthy volunteers. This clinical trial is an open study of safety, tolerability and immunogenicity of the drug “Gam-COVID-Vac Lyo”, lyophilisate for the preparation of a solution for intramuscular administration, with the participation of healthy volunteers.
Interested in learning whether current clinical programs, research developments, or emerging therapeutic approaches may be relevant to your situation?
Educational and research information only. Individual medical decisions should be made in consultation with qualified healthcare professionals.
